XML 52 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity
 12 Months Ended
Dec. 31, 2017
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
STOCKHOLDERS’ EQUITY

Our Board of Directors declared dividends on our outstanding shares of common stock as follows for the periods presented (in thousands, except per share amounts):

 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
Per Share Amount
 
Aggregate Amount
 
Per Share Amount
 
Aggregate Amount
 
Per Share Amount
 
Aggregate Amount
First Quarter
 
$
0.06

 
$
1,301

 
$
0.05

 
$
1,076

 
$
0.05

 
$
1,073

Second Quarter
 
$
0.06

 
$
2,561

 
$
0.06

 
$
1,300

 
$
0.05

 
$
1,077

Third Quarter
 
$
0.06

 
$
2,564

 
$
0.06

 
$
1,299

 
$
0.05

 
$
1,076

Fourth Quarter
 
$
0.06

 
$
2,565

 
$
0.06

 
$
1,299

 
$
0.05

 
$
1,076



On April 3, 2017, we completed the acquisition of AmCo by issuing 20,956,355 shares of our common stock as consideration for the final purchase price. See Note 4 for additional information on this acquisition.

On February 3, 2015, we completed the acquisition of FSH and its subsidiaries by issuing 503,857 shares of our common stock as consideration for the initial purchase price. In March 2016 we paid contingent consideration of 32,943 shares of common stock as part of the FSH acquisition.

See Note 20 for information regarding the activity of our common stock and share-based compensation.